- CA$3.83m
- CA$6.10m
- $6.34m
- 46
- 53
- 60
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.4 | 6.93 | 6.45 | 6.86 | 6.34 |
Cost of Revenue | |||||
Gross Profit | 2.98 | 1.07 | 1.28 | 0.766 | 0.772 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.88 | 7.44 | 6.48 | 8.13 | 7.55 |
Operating Profit | 0.494 | -0.509 | -0.023 | -1.28 | -1.21 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.508 | -0.588 | -0.204 | -1.24 | -1.32 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.556 | -0.588 | -0.204 | -1.24 | -1.32 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.556 | -0.588 | -0.204 | -1.24 | -1.32 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.556 | -0.588 | -0.204 | -1.24 | -1.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.003 | -0.007 | -0.006 | -0.008 | -0.009 |